Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peramivir in elderly and high-risk influenza patients
NCT02635724Phase 3Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Dec 2015
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Started Dec 2015; status: completed.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02635724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02635724.